ArticleFrontiers in neurology
Therapeutic pathways for ischemic stroke patients in France: a national hospitalization database study.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Ischemic strokes are of major public health impact in France, with more than 120,000 hospitalizations each year. Its main management relies on the possibility to perform thrombolysis within the first hours following the stroke in emergency room, stroke unit (SU) or with telemedicine. The objective of this study was to establish an overview of hospital care of stroke and identify therapeutic pathways, and their characteristics in France overall and by region. Methods: This is a non-interventional descriptive cross-sectional study using secondary data from the French national hospitalization database (PMSI). Hospital stays presenting a diagnosis of ischemic stroke between January 1, 2022, and December 31, 2023, were selected. Among them, therapeutic pathways were identified based on the type of care facility, the presence of mechanical thrombectomy, inter-hospital transfer, and type of discharge. Results: In 2023, 171,674 patients were hospitalized for stroke with 57.4% for ischemic stroke. At national level, 70% of hospital stays for ischemic stroke in 2023 were managed in SU, whereas these facilities represent only 13% of facilities in France. The network of SU providing stroke care is highly dependent on the region. Among all hospital stays, 78 distinct therapeutic pathways of management of ischemic stroke were identified. Among them, 11 represented 90% of the study population. Conclusion: The territorial organization of establishments, particularly those with a SU, is a key factor in the management of ischemic stroke. This optimization of pathways can have an impact on costs, length of stay, and the probability of returning home.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.